Skip to main content
Journal cover image

Toward a systems engineering approach to cancer drug delivery.

Publication ,  Journal Article
Dreher, MR; Chilkoti, A
Published in: Journal of the National Cancer Institute
July 2007

Duke Scholars

Published In

Journal of the National Cancer Institute

DOI

EISSN

1460-2105

ISSN

0027-8874

Publication Date

July 2007

Volume

99

Issue

13

Start / End Page

983 / 985

Related Subject Headings

  • Technology, Pharmaceutical
  • Systems Theory
  • Oncology & Carcinogenesis
  • Neovascularization, Pathologic
  • Neoplasms
  • Humans
  • Drug Delivery Systems
  • Drug Carriers
  • Antineoplastic Agents
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dreher, M. R., & Chilkoti, A. (2007). Toward a systems engineering approach to cancer drug delivery. Journal of the National Cancer Institute, 99(13), 983–985. https://doi.org/10.1093/jnci/djm042
Dreher, Matthew R., and Ashutosh Chilkoti. “Toward a systems engineering approach to cancer drug delivery.Journal of the National Cancer Institute 99, no. 13 (July 2007): 983–85. https://doi.org/10.1093/jnci/djm042.
Dreher MR, Chilkoti A. Toward a systems engineering approach to cancer drug delivery. Journal of the National Cancer Institute. 2007 Jul;99(13):983–5.
Dreher, Matthew R., and Ashutosh Chilkoti. “Toward a systems engineering approach to cancer drug delivery.Journal of the National Cancer Institute, vol. 99, no. 13, July 2007, pp. 983–85. Epmc, doi:10.1093/jnci/djm042.
Dreher MR, Chilkoti A. Toward a systems engineering approach to cancer drug delivery. Journal of the National Cancer Institute. 2007 Jul;99(13):983–985.
Journal cover image

Published In

Journal of the National Cancer Institute

DOI

EISSN

1460-2105

ISSN

0027-8874

Publication Date

July 2007

Volume

99

Issue

13

Start / End Page

983 / 985

Related Subject Headings

  • Technology, Pharmaceutical
  • Systems Theory
  • Oncology & Carcinogenesis
  • Neovascularization, Pathologic
  • Neoplasms
  • Humans
  • Drug Delivery Systems
  • Drug Carriers
  • Antineoplastic Agents
  • 3211 Oncology and carcinogenesis